Literature DB >> 14693762

Mitomycin C as an adjunct in the treatment of localised ocular surface squamous neoplasia.

C Chen1, D Louis, T Dodd, J Muecke.   

Abstract

AIM: To report the outcome of topical mitomycin C (MMC) used as adjunctive treatment following primary excision of ocular surface squamous neoplasia (OSSN).
METHOD: Prospective, non-comparative interventional case series of 27 primary OSSN lesions from 26 patients treated in a single ocular oncology centre over a 4 year period. RESULT: 27 cases of OSSN received a treatment regimen of surgical excision, followed by topical MMC. Mean follow up of 27 (SD 12) months (range 12-50, median 25 months) revealed zero recurrences.
CONCLUSION: MMC treatment following surgical excision decreases the recurrence rate of primary ocular surface neoplasia and should be considered as adjunctive therapy in primary treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693762      PMCID: PMC1771954          DOI: 10.1136/bjo.88.1.17

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Surgical management of ocular surface squamous neoplasms: the experience from a cornea center.

Authors:  S Sudesh; C J Rapuano; E J Cohen; R C Eagle; P R Laibson
Journal:  Cornea       Date:  2000-05       Impact factor: 2.651

2.  Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasias.

Authors:  E G Kemp; A N Harnett; S Chatterjee
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

3.  Mitomycin C treatment of conjunctival intraepithelial neoplasia.

Authors:  H E Grossniklaus; T M Aaberg
Journal:  Am J Ophthalmol       Date:  1997-09       Impact factor: 5.258

4.  Conjunctival squamous cell carcinoma with perineural invasion resulting in death.

Authors:  Andrew Kaines; Garry Davis; Dinesh Selva; Igal Leibovitch; Thomas Dodd; Raman Malhotra
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 May-Jun

Review 5.  Ocular surface squamous neoplasia.

Authors:  G A Lee; L W Hirst
Journal:  Surv Ophthalmol       Date:  1995 May-Jun       Impact factor: 6.048

Review 6.  Antimetabolites in ocular surface neoplasia.

Authors:  P A Majmudar; R J Epstein
Journal:  Curr Opin Ophthalmol       Date:  1998-08       Impact factor: 3.761

7.  Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.

Authors:  P A McKelvie; M Daniell
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

8.  Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.

Authors:  J Frucht-Pery; J Sugar; J Baum; J E Sutphin; J Pe'er; H Savir; E J Holland; D M Meisler; J A Foster; R Folberg; Y Rozenman
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

9.  Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.

Authors:  T J Heigle; R D Stulting; D A Palay
Journal:  Am J Ophthalmol       Date:  1997-09       Impact factor: 5.258

10.  Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.

Authors:  R R Vann; C L Karp
Journal:  Ophthalmology       Date:  1999-01       Impact factor: 12.079

View more
  13 in total

1.  Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison.

Authors:  Christina S Moon; Afshan A Nanji; Anat Galor; Kathryn E McCollister; Carol L Karp
Journal:  Ophthalmology       Date:  2015-12-11       Impact factor: 12.079

2.  Ocular surface squamous neoplasia.

Authors:  Sonali V Kumar; D Joshi
Journal:  Med J Armed Forces India       Date:  2018-07-30

3.  Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.

Authors:  Anat Galor; Carol L Karp; Patrick Oellers; Andrew A Kao; Amany Abdelaziz; William Feuer; Sander R Dubovy
Journal:  Ophthalmology       Date:  2012-06-14       Impact factor: 12.079

Review 4.  Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.

Authors:  Benjamin J Thomas; Anat Galor; Afshan A Nanji; Fouad El Sayyad; Jianhua Wang; Sander R Dubovy; Madhura G Joag; Carol L Karp
Journal:  Ocul Surf       Date:  2013-11-09       Impact factor: 5.033

5.  Topical treatment options for conjunctival neoplasms.

Authors:  Jonathan W Kim; David H Abramson
Journal:  Clin Ophthalmol       Date:  2008-09

6.  Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.

Authors:  Madhura G Joag; Adam Sise; Juan Carlos Murillo; Ibrahim Osama Sayed-Ahmed; James R Wong; Carolina Mercado; Anat Galor; Carol L Karp
Journal:  Ophthalmology       Date:  2016-03-27       Impact factor: 12.079

Review 7.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  Combined excision, cryotherapy, and intraoperative mitomycin C (EXCRIM) for localized intraepithelial and squamous cell carcinoma of the conjunctiva.

Authors:  Ahmet M Sarici; Sema Arvas; Halit Pazarli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-16       Impact factor: 3.117

9.  Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia.

Authors:  Ibrahim O Sayed-Ahmed; Sotiria Palioura; Anat Galor; Carol L Karp
Journal:  Expert Rev Ophthalmol       Date:  2016-12-05

Review 10.  Ocular surface squamous neoplasia: management and outcomes.

Authors:  Roland Hӧllhumer; Susan Williams; Pamela Michelow
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.